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Abstract: Gram-negative bacteria are an increasingly serious
source of antibiotic-resistant infections, partly owing to their
characteristic protective envelope. This complex, 20 nm thick
barrier includes a highly impermeable, asymmetric bilayer
outer membrane (OM), which plays a pivotal role in resisting
antibacterial chemotherapy. Nevertheless, the OM molecular
structure and its dynamics are poorly understood because the
structure is difficult to recreate or study in vitro. The successful
formation and characterization of a fully asymmetric model
envelope using Langmuir–Blodgett and Langmuir–Schaefer
methods is now reported. Neutron reflectivity and isotopic
labeling confirmed the expected structure and asymmetry and
showed that experiments with antibacterial proteins repro-
duced published in vivo behavior. By closely recreating natural
OM behavior, this model provides a much needed robust
system for antibiotic development.
Gram-negative bacteria, such as Escherichia coli, are
increasingly displaying antibiotic resistance,[1] partly because
they possess an outer membrane (OM) that forms a highly
selective filter around the target cell.[2] The OM structure is
unique in biology (Figure 1). Most biological membranes are
lipid bilayers with partial asymmetry in lipid content between
the two layers. By contrast, the OM asymmetry is profound,
creating a uniquely impermeable layer. The outer leaflet is
composed of lipopolysaccharide (LPS) molecules that com-
prise hydrophobic lipid A attached to phosphorylated sugar
chains of various lengths. Divalent cations cross-link anionic
LPS, which leads to the formation of a tight membrane and
two hurdles for the incoming molecules to overcome.
Hydrated saccharide chains prevent the ingress of hydro-
phobic or surface-active molecules, whilst the inner hydro-
phobic bilayer repels hydrophilic substances. Selective uptake
through integral outer membrane proteins (OMPs) ensures
that the cell receives the nutrients that it needs. These
properties limit the toxicity of all antimicrobials whereas
OMP mutations that further reduce OM permeability have
been found in antibiotic-resistant cells.[2] Understanding the
structure and function of the OM is therefore vital for human
health[3] but it is challenging because bacterial cells are very
Figure 1. Schematic representation of the Gram-negative bacterial
envelope, including the outer membrane (OM) with long “smooth”
LPSs, core-associated divalent cations, integral membrane proteins (in
this case, a channel-forming porin such as OmpF), and the inner
phospholipid layer. The periplasm and inner membrane contain many
proteins (not shown). Not to scale; the porins are approximately 5–
6 nm high, the periplasm about 14 nm, and the inner membrane
approximately 4 nm.
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small and the creation of accurate model systems is techni-
cally challenging.[4] As a result, although we have a clear
knowledge of the chemical composition of the OM, our
understanding of its physical and dynamic properties lags far
behind our knowledge of other biological membranes.[5]
Herein, we describe a method to create asymmetric
membrane models of the E. coli OM and reveal the unique
ability of neutron reflection (NR) to confirm the asymmetry
of the membrane models. The membrane “floats” on a water
layer above a phosphatidylcholine self-assembled monolayer
(SAM) on a smooth gold surface.[6] Although much thinner
than the bacterial periplasm (ca. 145 è),[7] which is stabilized
by peptidoglycans and other polymers, the approximately
15 è thick water layer combined with lipid asymmetry
renders this floating supported bilayer (FSB) a practical,
accurate, and useful synthetic OM model. The flat gold layer
is adhered to the silicon substrate through an intervening
permalloy layer enabling us to use magnetic-contrast NR to
confidently analyze this many-layered structure.[6,8]
First, the gold surface was coated with a SAM of w-
thiolipids.[6] The OM model was formed as an asymmetric
FSB by sequential Langmuir–Blodgett and Langmuir–Schae-
fer deposition of a deuterium-labeled phospholipid (d-DPPC)
followed by unlabeled LPS (Figure 2). The fitted data, from
a series of separate FSBs, revealed neutron scattering length
density (nSLD) profiles (see the Supporting Information,
Figures S3–S6 and Tables S1–S4) that are consistent with
asymmetric FSB on top of w-thiolipid-coated substrates.[6,8a]
The FSB consisted of a rough mutant LPS (Ra chemotype)
outer leaflet and a d-DPPC inner leaflet, which floated 12–
17 è above the choline head groups of the w-thiolipid SAM[9]
(Figure 3). These profiles were fitted to a model of the FSB
that consisted of a thin inner (d-DPPC) head-group layer,
inner and outer lipid-tail regions (14–18 è), and a thick outer
head-group region (28–30 è) corresponding to the LPS core
oligosaccharide (Tables S3–S6). The NR data analysis
revealed FSBs coverages of > 90% (Table S2) and asymme-
tries ranging from 69:28 and 23:75 (LPS/PC) in the outer and
inner leaflets, respectively, in the worst bilayer to 79:11 and
8:82 in the best. The thickness/nSLD profiles recorded for
these bilayers were consistent with previous studies[9a,10] and
with a model generated from atomistic molecular dynamics
simulations (Figure 4A).[11] The stability of the floating model
OM was examined against time and under different solution
conditions. Sample 1 was analyzed over 72 h and showed no
changes. The bilayers were also studied at two Ca2+ concen-
trations, 5 mm and 20 mm, and no differences in structure were
observed.
The usefulness of this model for antibiotic development
hangs upon its relevance to the natural OM. We thus tested
Figure 2. Fabrication of floating asymmetric OM models. A) Lang-
muir–Blodgett deposition of the DPPC layer on the SAM. B) Repeated
pressure–area curves of the Ra-LPS monolayer at the air–water inter-
face to confirm stability. C) Langmuir–Schaefer deposition of the Ra-
LPS layer. D) Structure of the complete OM model (inverted to enable
direct comparison with Figure 1). Red arrows indicate the direction of
movement of the substrate; calcium ions are shown as yellow spheres.
Figure 3. A) nSLD profiles of the OM model in different solution
isotopic (H2O and D2O) contrasts and a schematic representation of
the OM model. The permalloy layer provides a separate nSLD for each
neutron spin. The strong peaks of the deuterated DPPC tails versus
H2O (blue #) and the non-deuterated LPS tails versus D2O (red *),
which confirm asymmetry, are evident. C) Original data points (black)
from two spin polarizations with fitted lines that correspond to the
nSLD profiles in (A). The two data sets relate to samples examined in
a D2O buffer solution using neutrons in a spin-up configuration (red)
and in a H2O buffer solution using spin-down neutrons (blue). Colored
shading indicates the 95% confidence limits of the fitted model, see
the Supporting Information for details.
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the response of the model to either divalent-cation removal or
antimicrobial proteins. Their interactions with the OM in vivo
and in vitro are well known,[12] enabling direct comparisons
with our model.
In vivo, divalent-cation removal by EDTA treatment of
Gram-negative bacteria removes the LPS from the OM,
leading to the appearance of phospholipids in the outer
leaflet[12c] (which is likely due to mixing across the OM).[10]
The OMmodel was examined in 5 mm Ca2+ and 3 mm EDTA
solutions. Upon the sequestration of Ca2+ by EDTA, the
bilayer asymmetry was reduced in both the inner and outer
leaflets by approximately 20% (see Figure 4B, Figures S6, S7,
and Tables S5, S6). Recently, we obtained a similar result
using silicon-supported asymmetric OMmimics.[10] In the MD
simulation, we imitated EDTA addition by replacing the
divalent cations with twice the number of monovalent ions,
keeping the whole system electroneutral. After 200 ns, the
asymmetry had clearly already broken down, and the rough-
ness of the bilayer had increased, which is in agreement with
the experimental observations (Figure 4A).
Humans produce antimicrobial proteins, including lyso-
zyme and lactoferrin, as part of their innate immune system.
Lactoferrin is cationic (pI 8.0–8.5) and acts directly upon the
OM through electrostatic interactions with the anionic core
oligosaccharide region.[12b] It has been suggested that it
disrupts the divalent-cation bridges between neighboring
LPS molecules, causing their release into the bulk solution.
On the other hand, the cationic enzyme lysozyme (pI 11) is
much less active against Gram-negative than against Gram-
positive bacteria as it cannot easily pass through the OM to
digest periplasmic peptidoglycan.[12a]
As the nSLD profiles of proteins are different from those
of LPS and d-DPPC, we can define the protein layer by NR.
The interaction of lactoferrin (40 mgmL¢1) with the OM
model reduced membrane coverage by 12% and the bilayer
leaflet asymmetry by approximately 30%. The 90 è increase
in the thickness of the LPS core region (see Figure 5A and
Figures S5, S8 and Tables S5, S8) agrees with the suggested
electrostatic binding of lactoferrin to the core oligosacchar-
ide. It implies that the protein is bound to the bilayer with its
major axis parallel to the membrane normal, as the prolate
protein is approximately 90 è in length along its longest
axis.[13] These data provide the first structural picture of
lactoferrin disrupting the OM. In the laboratory, lysozyme is
often combined with EDTA to remove the outer membrane
and the peptidoglycans from Gram-negative bacteria. Having
already measured the large effect of EDTA, we investigated
the interaction of lysozyme alone with an intact FSB in 20 mm
Ca2+ solution. The thickness of the core oligosaccharide
region increased by 20 è, suggesting that this cationic protein
has bound electrostatically to the anionic region of the outer
leaflet (Figure 5B, Figures S3, S9, Tables S3, S9). There was
no loss of FSB coverage, but the bilayer roughness increased
from 9.31 (range 8.35,10.0) to 12.88 (7.36,18.22) è. Fitting of
the data also suggested a minor decrease in asymmetry, albeit
Figure 4. A) MD simulation of an LPS–PC asymmetric bilayer after
500 ns with Ca2+ (left) and 200 ns after replacement of the Ca2+ ions
by twice the amount of Na+ ions (right). B) nSLD profiles obtained by
fitting the neutron reflectivity data of an asymmetric DPPC/Ra-LPS
system in the presence of 5 mm Ca2+ (left) and after calcium
sequestration by EDTA (right). Schematic representations of the
structures that these profiles describe are also shown, these were
determined through interpretation of the fitting parameters and the
resulting SLD profiles using the known scattering length densities of
the bilayer components and the aqueous solutions (see the Supporting
Information). Note the reduced packing/asymmetry and increased
roughness.
Figure 5. A,B) nSLD profiles and schematic representations of the OM
model before and after protein addition: A) lactoferrin (LF;
40 mgmL¢1), B) lysozyme (Lyz; 200 mgmL¢1) in 20 mm HEPES buffer
(pH/D 7.2, 20 mm CaCl2 ; see the Supporting Information for further
details).
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within error limits. These results agree with the previously
observed differences[12a] in the abilities of each protein to
disrupt the OM.
In conclusion, we have presented models of the OM that
are asymmetric, rest on a water-filled layer, and contain rough
bacterial lipopolysaccharides. These bilayer models are not
only amenable to structural characterization by neutron
reflection, but can, in principle, be studied by techniques
such as surface plasmon resonance, infrared spectroscopy,
atomic force microscopy, and FRET. The gold surface
presents problems related to fluorescence quenching and
opacity, which can be overcome by the use of PC-modified
silicon substrates.[14] The models will enable studies of the
interactions of antibacterial molecules, including small-mol-
ecule antibiotics,[2] polymyxins/colistins, and colicins,[15] with
the OM surface under conditions that are close to, but much
more tractable than, those found in vivo. Intact OMPs can be
incorporated during the Langmuir–Schaeffer step, and we are
currently enhancing the nSLD contrast of the OMPs to define
their structure in the FSB.[16] Finally, we are developing
methods to incorporate smooth lipopolysaccharides.
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